Eleni-dimitra Papanagnou

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Proteostasis is disrupted in human endothelial cells by serum from ATTR patients and is rescued by tafamidis treatment.

Proteostasis is disrupted in human endothelial cells by serum from ATTR patients and is rescued by tafamidis treatment.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: June 26, 2026

Implications and hidden toxicity of cardiometabolic syndrome and early-stage heart failure in carfilzomib-induced cardiotoxicity.

Implications and hidden toxicity of cardiometabolic syndrome and early-stage heart failure in carfilzomib-induced cardiotoxicity.

Journal: British journal of pharmacology
Published: March 16, 2023

Boosting autophagy in anti-tumor proteasome inhibition-mediated cardiotoxicity.

Boosting autophagy in anti-tumor proteasome inhibition-mediated cardiotoxicity.

Journal: Aging
Published: December 28, 2022

Autophagy activation can partially rescue proteasome dysfunction-mediated cardiac toxicity.

Autophagy activation can partially rescue proteasome dysfunction-mediated cardiac toxicity.

Journal: Aging cell
Published: April 04, 2022

Cardiac mechanics in response to proteasome inhibition: a prospective study.

Cardiac mechanics in response to proteasome inhibition: a prospective study.

Journal: European heart journal. Cardiovascular Imaging
Published: March 13, 2022

Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy.

Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy.

Journal: Blood
Published: November 29, 2021

Sustained but Declining Humoral Immunity Against SARS-CoV-2 at 9 Months Postvaccination With BNT162b2: A Prospective Evaluation in 309 Healthy Individuals.

Sustained but Declining Humoral Immunity Against SARS-CoV-2 at 9 Months Postvaccination With BNT162b2: A Prospective Evaluation in 309 Healthy Individuals.

Journal: HemaSphere
Published: October 31, 2021

Isolation of an Extract from the Soft Coral Symbiotic Microorganism Salinispora arenicola Exerting Cytoprotective and Anti-Aging Effects.

Isolation of an Extract from the Soft Coral Symbiotic Microorganism Salinispora arenicola Exerting Cytoprotective and Anti-Aging Effects.

Journal: Current issues in molecular biology
Published: October 15, 2021

Robust Neutralizing Antibody Responses 6 Months Post Vaccination with BNT162b2: A Prospective Study in 308 Healthy Individuals.

Robust Neutralizing Antibody Responses 6 Months Post Vaccination with BNT162b2: A Prospective Study in 308 Healthy Individuals.

Journal: Life (Basel, Switzerland)
Published: October 01, 2021

Myeloma patients with COVID-19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine.

Myeloma patients with COVID-19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine.

Journal: British journal of haematology
Published: August 03, 2021

Micro-CT for Biological and Biomedical Studies: A Comparison of Imaging Techniques.

Micro-CT for Biological and Biomedical Studies: A Comparison of Imaging Techniques.

Journal: Journal of imaging
Published: July 17, 2021

The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment.

The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment.

Journal: Blood cancer journal
Published: June 09, 2021
Showing 1-12 of 29

Last Updated: 09/26/2026